Research Article

KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?

Table 3

BRAF, phenotype, and genotype.

CaseSexAge (years)BRAF staining Molecular status

AF55PositiveMutated, MSI
BM64PositiveMutated, MSI
CM72PositiveMutated, MSI
DM75PositiveMutated, MSI
EM71PositiveMutated, MSI
FF61PositiveMutated, MSI
GF81PositiveMutated, MSI
HM81PositiveMutated, MSI
IM65PositiveMutated, MSI
JM74PositiveMutated, MSI
KM54PositiveMutated, MSS
LM58PositiveMutated, MSS
MM23PositiveMutated, MSS
NF50PositiveMutated, MSS
OM50PositiveMutated, MSS
PF50PositiveMutated, MSS
QM61PositiveMutated, MSS
RM62PositiveMutated, MSS
SF67PositiveMutated, MSS
TM56PositiveMutated, MSS
UF56NegativeWild type, MSS
VM63NegativeWild type, MSS
WF62NegativeWild type, MSS
XF42NegativeWild type, MSS
YM56NegativeWild type, MSS
ZF64NegativeWild type, MSS
AAF61NegativeWild type, MSS
ABM60NegativeWild type, MSS
ACM52NegativeWild type, MSS
ADM54NegativeWild type, MSS

F: female; M: male; MSI: microsatellite-instable; MSS: microsatellite-stable.